Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06586645
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-04
Brief Title:
Evaluation of a Brief Scalable Module to Mitigate Suicidal Ideation Among Youth
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Evaluation of a Brief Scalable Module to Mitigate Suicidal Ideation Among Youth
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This project is designed to test a brief therapy to reduce suicidal ideation among a diverse sample of youths ages 12 to 17 who experience anxiety or depression The goal of the study is to conduct a clinical trial testing whether this therapy reduces suicidal ideation and related beliefs that one is a burden on others This project will contribute to the field by potentially showing evidence supportive of a brief strategy to reduce suicidal ideation in a way that can be readily understood and used by mental health providers in the community
Detailed Description:
This project tests the ability of a brief therapy module to engage youth perceived burdensomeness PB in a rigorous randomized controlled trial RCT of the intervention the 34Give to Others GO34 module The investigators will target PB among 60 ethnicallyracially diverse clinic-referred youths ages 12-17 who experience subacute suicide ideation SI ie positive suicide risk screen stable safety status Youths will be recruited from the clinical and community settings and will be randomized to one of the following 2 arms an assessment and suicide risk management condition Safety Planning control arm and a Safety Planning plus GO module condition The investigators hypothesize that youths receiving the GO module will have lower levels of PB at post-treatment compared with youths who receive the control arm The investigators also hypothesize that youths receiving the GO module will have lower levels of PB at post-treatment compared to pre-treatment levels
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None